KRAS and pancreatitis: In closing, our results demonstrate that mice lacking Sirt2 exhibit a pancreatic inflammation permissive phenotype, as well as accumulate oncogenic Kras mutations that is accelerated during recovery from caerulein-induced pancreatitis.